Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
18.20
-0.06 (-0.33%)
Oct 26, 2026, 9:39 AM EDT - Market open
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.08 billion as of October 26, 2026. It is the 9,638th most valuable company in the world and the 2,183rd biggest in the United States. Its market cap has increased by 477.79% in one year.
Market Cap
1.08B
Enterprise Value
613.50M
1-Year Change
477.79%
Global Rank
Country Rank
#2,183 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $1.08B, a decrease of -17.11%. That is a compound annual growth rate of -3.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.08B | 112.60% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalyn Pharma | 1.15B |
| Bicara Therapeutics | 1.13B |
| Seaport Therapeutics | 1.10B |
| Replimune Group | 1.08B |
| Savara | 1.07B |
| ArriVent BioPharma | 1.04B |
| City Therapeutics | 1.03B |
| MannKind | 1.03B |